2.44
1.67%
0.04
After Hours:
2.45
0.01
+0.41%
Ambev S A Adr stock is traded at $2.44, with a volume of 37.25M.
It is up +1.67% in the last 24 hours and up +7.49% over the past month.
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving Interbrew (now AB InBev) a controlling interest of 61.8% as at the end of 2023.
See More
Previous Close:
$2.40
Open:
$2.39
24h Volume:
37.25M
Relative Volume:
1.48
Market Cap:
$38.19B
Revenue:
$16.14B
Net Income/Loss:
$2.89B
P/E Ratio:
13.53
EPS:
0.1804
Net Cash Flow:
$4.06B
1W Performance:
+5.63%
1M Performance:
+7.49%
6M Performance:
-1.61%
1Y Performance:
-5.43%
Ambev S A Adr Stock (ABEV) Company Profile
Name
Ambev S A Adr
Sector
Industry
Phone
-
Address
-
Ambev S A Adr Stock (ABEV) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-08-23 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
Dec-07-23 | Initiated | Citigroup | Buy |
Nov-22-23 | Initiated | Jefferies | Hold |
Jul-10-23 | Upgrade | BofA Securities | Neutral → Buy |
May-24-23 | Initiated | Bernstein | Outperform |
Jan-12-23 | Upgrade | UBS | Sell → Buy |
Jul-13-22 | Upgrade | JP Morgan | Neutral → Overweight |
Nov-03-21 | Upgrade | BofA Securities | Underperform → Neutral |
Oct-06-21 | Upgrade | Barclays | Equal Weight → Overweight |
Aug-13-21 | Initiated | Goldman | Sell |
Jun-17-21 | Upgrade | Barclays | Underweight → Equal Weight |
May-20-21 | Downgrade | Itau BBA | Outperform → Market Perform |
Apr-26-21 | Downgrade | Citigroup | Buy → Neutral |
Nov-03-20 | Upgrade | Citigroup | Neutral → Buy |
Jul-31-20 | Upgrade | JP Morgan | Underweight → Neutral |
Mar-24-20 | Downgrade | JP Morgan | Neutral → Underweight |
Feb-25-20 | Downgrade | HSBC Securities | Hold → Reduce |
Dec-03-19 | Downgrade | Barclays | Equal Weight → Underweight |
Aug-27-19 | Downgrade | Barclays | Overweight → Equal Weight |
Jul-26-19 | Upgrade | JP Morgan | Underweight → Neutral |
May-21-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
Oct-25-18 | Downgrade | JP Morgan | Neutral → Underweight |
Oct-27-17 | Reiterated | Barclays | Equal Weight |
Sep-12-17 | Upgrade | Credit Suisse | Neutral → Outperform |
Nov-10-16 | Upgrade | JP Morgan | Neutral → Overweight |
Nov-03-16 | Resumed | Barclays | Equal Weight |
Aug-18-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
May-05-16 | Downgrade | JP Morgan | Overweight → Neutral |
Jun-01-15 | Upgrade | JP Morgan | Neutral → Overweight |
View All
Ambev S A Adr Stock (ABEV) Latest News
Barclays slashes price target on Ambev S.A. ADR [ABEV] – find out why. - The DBT News
Ambev S.A. ADR (ABEV) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
A closer look at ABEV’s price-to-free cash flow ratio - US Post News
Ambev S.A. ADR (ABEV) Stock Behavior Is Not Predictable - Stocks Register
Anheuser-Busch InBev S.A. ADR underperforms Monday when compared to competitors - MarketWatch
ABEV’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Sold by Davidson Kempner Capital Management LP - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Bought by Heron Bay Capital Management - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Shares Bought by Callan Capital LLC - Defense World
Anheuser-Busch InBev SA/NV (NYSE:BUD) Stake Increased by Moors & Cabot Inc. - Defense World
DekaBank Deutsche Girozentrale Makes New $1.08 Million Investment in Anheuser-Busch InBev SA/NV (NYSE:BUD) - MarketBeat
Capco Asset Management LLC Buys 7,193 Shares of Anheuser-Busch InBev SA/NV (NYSE:BUD) - Defense World
ABEV Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
ABEV’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Up 0.78%: This Is What Analysts Are Now Forecasting - Stocks Register
Nothing is Better Than Ambev S.A. ADR (ABEV) stock at the moment - SETE News
The ABEV Stock Puzzle: Unraveling Ambev S.A. ADR’s Fluctuating Performance - The InvestChronicle
Barclays lifts Ambev S.A. ADR [ABEV] price estimate. Who else is bullish? - The DBT News
What to expect from ABEV’s earnings report this quarter? - US Post News
Weekly Upgrades and Downgrades - InvestorPlace
Does Ambev S.A. ADR (NYSE: ABEV) Still Need To Convince Analysts? - Stocks Register
The 10 Best Companies to Invest in Now - Morningstar
Ambev S.A. ADR [ABEV] fell -18.93% so far this year. What now? - The DBT News
Ambev S.A. ADR (ABEV) Stock: A Year of Market Fluctuations - The InvestChronicle
Get in on Ambev S.A. ADR’s (ABEV) buy-in window today! - SETE News
ABEV stock’s current quarter earnings estimates: What analysts predict? - US Post News
A better buy-in window may exist right now for Ambev S.A. ADR (ABEV) - SETE News
Closing Bell Recap: Ambev S.A. ADR (ABEV) Ends at 2.33, Reflecting a -1.27 Downturn - The Dwinnex
Right Now, Here’s How You Can Trade Ambev S.A. ADR (ABEV) Aggressively - US Post News
ABEV: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Ambev S.A. ADR [ABEV] Stock trading around $2.39 per share: What’s Next? - The DBT News
Our Attention Has Been Attracted to Ambev S.A. ADR (NYSE:ABEV) - US Post News
Views of Wall Street’s Leading Experts on Ambev S.A. ADR - SETE News
The Significance of Moving Averages in Ambev S.A. ADR Inc. (ABEV) Price Performance - The InvestChronicle
ABEV’s 2023 Market Dance: Down -19.29% – Time to Invest? - The InvestChronicle
Earnings call: Ambev reports growth amid challenges in Q2 - Investing.com
Daily Progress: Ambev S.A. ADR (ABEV) Drop -1.44, Closing at 2.06 - The Dwinnex
SEC Form 6-K filed by Ambev S.A. - Quantisnow
Ambev S.A. ADR (ABEV) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Ambev S.A. ADR (ABEV)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
ABEV: 3 Brewers Stocks to Quench Your Portfolio's Thirst - StockNews.com
Ambev S.A. ADR: Rising -30.90% from 52-Week Low, Can the Stock Stay Afloat? - The InvestChronicle
A review of ABEV’s current quarter earnings predictions - US Post News
Ambev S.A. ADR (ABEV) Stock: From Low to High in 52 Weeks - The InvestChronicle
The Best Defensive Stocks to Buy - Morningstar
ABEV: 3 Beverage Stocks Benefiting from Consumer Preferences - StockNews.com
It makes sense and dollars to buy Ambev S.A. ADR (ABEV) stock - SETE News
Daily Market Movement: Ambev S.A. ADR (ABEV) Sees a 1.92 Increase, Closing at 2.12 - The Dwinnex
11 Best Stocks To Buy Under $5 in September 2024 - The Stock Dork
Ambev S.A. ADR (ABEV) Stock: Navigating a Year of Volatility - The InvestChronicle
Ambev S.A. ADR [ABEV] moved down -1.91: Why It's Important – The DBT News - The DBT News
Ambev S A Adr Stock (ABEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):